Connect your AI

CorMedix CRMD Total Current Assets

Total Current Assets at other companies

PfizerPFE

$42.82B-6.6%

Merck & Co.MRK

$35.02B-1.4%

Merit Medical SystemsMMSI

$1.1B+14.9%

ITG

Integer HoldingsITGR

$774.76M+10.3%

IAR

Integra LifeSciencesIART

$1.17B+5.8%

AbbottABT

$25.51B+10.2%

Other financials

Income statement

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CorMedix's total current assets?: CorMedix (CRMD) reported total current assets of $383.11M in Q1 2026.
How has CorMedix's total current assets changed year-over-year?: CorMedix's total current assets increased by 164.5% year-over-year, from $144.86M to $383.11M.
What is the long-term trend for CorMedix's total current assets?: Over 5 years (2020 to 2025), CorMedix's total current assets has grown at a 50.1% compound annual growth rate (CAGR), from $48.18M to $367.05M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.